Signaling, polyubiquitination, trafficking, and inclusions: Sequestosome 1/p62's role in neurodegenerative disease

被引:87
作者
Wooten, Marie W. [1 ]
Hu, Xiao [1 ]
Babu, J. Ramesh [1 ]
Seibenhener, M. Lamar [1 ]
Geetha, Thangiah [1 ]
Paine, Michael G. [1 ]
Wooten, Andmichael C. [1 ]
机构
[1] Auburn Univ, Dept Biol Sci, Program Cell Mol Biosci, Auburn, AL 36849 USA
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2006年
关键词
D O I
10.1155/JBB/2006/62079
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aggregated misfolded proteins are hallmarks of most neurodegenerative diseases. In a chronic disease state, including pathologic situations of oxidative stress, these proteins are sequestered into inclusions. Accumulation of aggregated proteins can be prevented by chaperones, or by targeting their degradation to the UPS. If the accumulation of these proteins exceeds their degradation, they may impair the function of the proteasome. Alternatively, the function of the proteasome may be preserved by directing aggregated proteins to the autophagy-lysosome pathway for degradation. Sequestosome 1/p62 has recently been shown to interact with polyubiquitinated proteins through its UBA domain and may direct proteins to either the UPS or autophagosome. P62 is present in neuronal inclusions of individuals with Alzheimer's disease and other neurodegenerative diseases. Herein, we review p62's role in signaling, aggregation, and inclusion formation, and specifically as a possible contributor to Alzheimer's disease. The use of p62 as a potential target for the development of therapeutics and as a disease biomarker is also discussed.
引用
收藏
页数:12
相关论文
共 86 条
[1]   Ubiquitin, cellular inclusions and their role in neurodegeneration [J].
Alves-Rodrigues, A ;
Gregori, L ;
Figueiredo-Pereira, ME .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :516-520
[2]   Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination [J].
Alwan, HAJ ;
van Zoelen, EJJ ;
van Leeuwen, JEM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35781-35790
[3]  
Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078
[4]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[5]   Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation [J].
Babu, JR ;
Geetha, T ;
Wooten, MW .
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (01) :192-203
[6]   The role of the ubiquitin-proteasome pathway in the formation of Mallory bodies [J].
Bardag-Gorce, F ;
van Leeuwen, FW ;
Nguyen, V ;
French, BA ;
Li, J ;
Riley, N ;
McPhaul, LW ;
Lue, YH ;
French, SW .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2002, 73 (02) :75-83
[7]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[8]   Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation [J].
Bennett, EJ ;
Bence, NF ;
Jayakumar, R ;
Kopito, RR .
MOLECULAR CELL, 2005, 17 (03) :351-365
[9]   Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration [J].
Berke, SJS ;
Paulson, HL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (03) :253-261
[10]   Family-based association between Alzheimer's disease and variants in UBQLN1 [J].
Bertram, L ;
Hiltunen, M ;
Parkinson, M ;
Ingelsson, M ;
Lange, C ;
Ramasamy, K ;
Mullin, K ;
Menon, R ;
Sampson, AJ ;
Hsiao, MY ;
Elliott, KJ ;
Velicelebi, G ;
Moscarillo, T ;
Hyman, BT ;
Wagner, SL ;
Becker, KD ;
Blacker, D ;
Tanzi, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09) :884-894